Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients
Ministère de l'Économie, de l’Innovation et des Exportations du Québec
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients
Audrey Glory, Érica Patocskai, Philip W. Wong
Citations
1 citations
Journal
BMC Cancer
Topics
Plasma Applications and Diagnostics
Field-Weighted Citation Impact (FWCI)
1.36
article
Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients
Audrey Glory, Érica Patocskai, Philip W. Wong
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Centre Hospitalier de l’Université de Montréal (CA)
Funders
Ministère de l'Économie, de l’Innovation et des Exportations du Québec
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients — Audrey Glory, Érica Patocskai, et al. · BMC Cancer (2025) | TGRS Research Map | TGRS